184 related articles for article (PubMed ID: 9916935)
1. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy.
Hölschermann H; Bohle RM; Zeller H; Schmidt H; Stahl U; Fink L; Grimm H; Tillmanns H; Haberbosch W
Am J Pathol; 1999 Jan; 154(1):211-20. PubMed ID: 9916935
[TBL] [Abstract][Full Text] [Related]
2. Microvascular thrombosis and cardiac allograft vasculopathy in rat heart transplantation.
Labarrere CA; Ortiz MA; Ruzmetov N; Sosa MJ; Campana G; Terry C; Baldridge LA; Antonopoulos R; DiCarlo HL
J Heart Lung Transplant; 2006 Oct; 25(10):1213-22. PubMed ID: 17045934
[TBL] [Abstract][Full Text] [Related]
3. Experimental cardiac allograft vasculopathy in mice.
Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
[TBL] [Abstract][Full Text] [Related]
4. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts.
Hölschermann H; Bohle RM; Schmidt H; Zeller H; Fink L; Stahl U; Grimm H; Tillmanns H; Haberbosch W
Circulation; 2000 Jul; 102(3):357-63. PubMed ID: 10899102
[TBL] [Abstract][Full Text] [Related]
5. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
[TBL] [Abstract][Full Text] [Related]
7. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation.
Ballantyne CM; Masri BM; Clubb FJ; Radovancević B; Smith CW; Hawkins HK; Frazier OH; Willerson JT
Tex Heart Inst J; 1996; 23(4):293-5. PubMed ID: 8969030
[TBL] [Abstract][Full Text] [Related]
9. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
[TBL] [Abstract][Full Text] [Related]
10. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
[TBL] [Abstract][Full Text] [Related]
13. Bax and apoptosis in acute and chronic rejection of rat cardiac allografts.
Dong C; Granville DJ; Tuffnel CE; Kenyon J; English D; Wilson JE; McManus BM
Lab Invest; 1999 Dec; 79(12):1643-53. PubMed ID: 10616213
[TBL] [Abstract][Full Text] [Related]
14. Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.
Huibers MM; Vink A; Kaldeway J; Huisman A; Timmermans K; Leenders M; Schipper ME; Lahpor JR; Kirkels HJ; Klöpping C; de Jonge N; de Weger RA
Atherosclerosis; 2014 Oct; 236(2):353-9. PubMed ID: 25128973
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
[TBL] [Abstract][Full Text] [Related]
16. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.
Haji SA; Starling RC; Avery RK; Mawhorter S; Tuzcu EM; Schoenhagen P; Cook DJ; Ratliff NB; McCarthy PM; Young JB; Yamani MH
J Heart Lung Transplant; 2004 Mar; 23(3):277-83. PubMed ID: 15019636
[TBL] [Abstract][Full Text] [Related]
17. New developments in the diagnosis and management of cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
[TBL] [Abstract][Full Text] [Related]
18. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
Hariya A; Takazawa K; Yamamoto T; Amano A
J Heart Lung Transplant; 2004 Oct; 23(10):1163-9. PubMed ID: 15477110
[TBL] [Abstract][Full Text] [Related]
19. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis.
Lin H; Wilson JE; Roberts CR; Horley KJ; Winters GL; Costanzo MR; McManus BM
J Heart Lung Transplant; 1996 Dec; 15(12):1233-47. PubMed ID: 8981209
[TBL] [Abstract][Full Text] [Related]
20. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
